CSCS

HPRC Physical Therapy Announces Partnership with Excel Physical Therapy

Retrieved on: 
Thursday, August 31, 2023

COLUMBUS, Ga., Aug. 31, 2023 /PRNewswire-PRWeb/ -- HPRC Physical Therapy (HPRC) proudly announces its latest partnership with Excel Physical Therapy (Excel PT), a therapist-owned physical therapy practice located in Hampton, GA. This partnership is an exciting opportunity for both companies to expand their reach and provide even more comprehensive care to patients throughout the region.

Key Points: 
  • COLUMBUS, Ga., Aug. 31, 2023 /PRNewswire-PRWeb/ -- HPRC Physical Therapy (HPRC) proudly announces its latest partnership with Excel Physical Therapy (Excel PT) , a therapist-owned physical therapy practice located in Hampton, GA.
  • "We couldn't be more excited to be joining the HPRC Physical Therapy family.
  • This partnership expands access to our physical therapy services to 15 clinics across Alabama, Georgia, and South Carolina.
  • To schedule an appointment with one of Excel PT's expert therapists, visit their website at excelptotga.com or call 770-603-7050.

Top Rated Physical Therapy Group Secures Partnership with University of Louisville Athletics

Retrieved on: 
Wednesday, August 23, 2023

LOUISVILLE, Ky., Aug. 23, 2023 /PRNewswire-PRWeb/ -- Physical Therapy (PRPT) takes great pride in announcing its first-ever collaboration with the University of Louisville (UofL) and Cardinal Sports as an Official Partner of University of Louisville Athletics for the upcoming 2023-2024 athletic season.

Key Points: 
  • ProRehab Physical Therapy, one of Kentucky's top rated physical and occupation therapy experts, is now a Louisville Athletics sponsor
    LOUISVILLE, Ky., Aug. 23, 2023 /PRNewswire-PRWeb/ -- Physical Therapy (PRPT) takes great pride in announcing its first-ever collaboration with the University of Louisville (UofL) and Cardinal Sports as an Official Partner of University of Louisville Athletics for the upcoming 2023-2024 athletic season.
  • "This partnership aligns perfectly with our mission to positively impact the communities we serve by delivering best-in-class musculoskeletal care and advancing physical therapy practices through evidence-based research."
  • CEO of Confluent Health, Dr. Kristi Henderson, DNP, FAAN, also expressed her enthusiasm for the partnership, stating, "We are excited to see ProRehab Physical Therapy collaborate with University of Louisville Athletics.
  • "The partnership between ProRehab Physical Therapy and University of Louisville Athletics has created a power team between top-tier physical therapists and top-performing collegiate athletes," added Dr. Benz.

Brooks Rehabilitation Continues Expansion in Orlando Market, Announces New Physical Therapy Outpatient Clinic in Horizon West

Retrieved on: 
Thursday, August 17, 2023

ORLANDO, Fla., Aug. 17, 2023 /PRNewswire/ -- Brooks Rehabilitation continues to grow in the Orlando market to address the demand for – and to provide necessary access to – physical therapy (PT), occupational therapy (OT) and speech-language pathology (SLP). The nonprofit will open its 12th Central Florida outpatient clinic August 23 in Horizon West at 15820 Shaddock Drive, Suite 110, Winter Garden, FL 34787.

Key Points: 
  • The nonprofit will open its 12th Central Florida outpatient clinic August 23 in Horizon West at 15820 Shaddock Drive, Suite 110, Winter Garden, FL 34787.
  • Brooks is currently accepting patients at its new Horizon West clinic, located off Porter Road directly across from Orlando Health Horizon West Hospital.
  • Physical therapy services at Horizon West include sports medicine, orthopedic physical therapy, post-operative physical therapy, geriatric physical therapy and worker's compensation.
  • The Horizon West clinic joins the growing number of Brooks outpatient clinics throughout the state, bringing the total number to 51.

IncludeHealth Secures $1.5M TACFI Award from US Air Force to Reduce Injuries Among Service Members and Expand Digital Musculoskeletal Platform

Retrieved on: 
Tuesday, July 18, 2023

The funding will support the expansion of IncludeHealth's innovative hybrid MSK platform to reduce musculoskeletal injuries among service members.

Key Points: 
  • The funding will support the expansion of IncludeHealth's innovative hybrid MSK platform to reduce musculoskeletal injuries among service members.
  • The award comes in collaboration with the 2nd Air Support Operations Squadron (2nd ASOS).
  • Musculoskeletal injuries (MSI) are a significant challenge for the military, leading to numerous medical visits, lost duty days, and high healthcare costs.
  • The innovations developed through this TACFI effort will also be available to IncludeHealth’s commercial customers, further advancing musculoskeletal care across the industry.

The Dairy Alliance Redefines the Role of Milk at the Peachtree Health & Fitness Expo

Retrieved on: 
Tuesday, June 27, 2023

ATLANTA, June 27, 2023 /PRNewswire/ -- Publix is partnering with The Dairy Alliance, a nonprofit redefining the vitality of milk's advancements in personal performance, by showing up at the Peachtree Health & Fitness Expo presented by Publix at the Georgia World Congress Center in Atlanta, with 4,000 bottles of milk to giveaway. The Dairy Alliance and Publix are working together to educate attendees and racers at the Expo on how they can achieve their personal best by drinking dairy milk.

Key Points: 
  • The Dairy Alliance and Publix are working together to educate attendees and racers at the Expo on how they can achieve their personal best by drinking dairy milk.
  • Researchers credit milk's natural electrolytes, carbohydrates, and high-quality protein for its effectiveness that surpasses water and sports drinks.
  • "At Publix, we're honored to team up with the Dairy Alliance to support the Atlanta Community Food Bank.
  • For more information about the nutritional benefits of milk, dairy recipe ideas, and more, visit www.thedairyalliance.com .

Propanc Biopharma Provides Shareholder Update

Retrieved on: 
Thursday, June 22, 2023

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced a shareholder update including recent developments and forecast for 2023/24, as Propanc prepares to file a Form 10-K annual report, whose fiscal year end is June 30.

Key Points: 
  • Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced a shareholder update including recent developments and forecast for 2023/24, as Propanc prepares to file a Form 10-K annual report, whose fiscal year end is June 30.
  • Propanc recently filed a post-effective Form S-1 amendment on behalf the lead investor who has funded approximately $2.25 million to date.
  • Propanc plans to compile the Investigational Medicinal Product Dossier, study proposal and Investigator’s Brochure in 2023.
  • To date, Propanc has raised approximately $23 million dollars, culminating in the Company’s lead asset ready to commence clinical development, and a backup clinical compound entering preclinical stage.

Athletico Physical Therapy Opens in Parma, Ohio

Retrieved on: 
Thursday, June 15, 2023

PARMA, Ohio, June 15, 2023 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Parma, Ohio, located in the complex near American Freight – Appliance, Furniture, Mattress. This location offers convenient hours, including early morning and late evening appointments, and does not require a referral or prescription to start treatment. To learn more, or to schedule a free assessment, visit www.athletico.com/Parma.

Key Points: 
  • PARMA, Ohio, June 15, 2023 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Parma, Ohio, located in the complex near American Freight – Appliance, Furniture, Mattress.
  • Patients have the option to have their condition assessed and treated virtually by a licensed physical therapist through a secure online video chat.
  • Services available at Athletico Parma include:
    Physical therapy – Our physical therapists treat you to reduce pain, improve or restore mobility, and to help you remain at your optimal health without further risk of injury.
  • We also offer joint replacement therapy, headache treatment, concussion therapy and more.

MedStar Health Teams up with Local Sports Figures to Teach CPR and AED with Video Campaign Launched for CPR & AED Awareness Week

Retrieved on: 
Thursday, June 1, 2023

COLUMBIA, Md., June 1, 2023 /PRNewswire/ -- Emergency and critical care physicians from MedStar Health have teamed up with former and current players and staff from local sports teams to teach CPR and how to use an Automated External Defibrillator (AED) with a video campaign to address disparities in who is most likely to receive life-saving CPR from a bystander.

Key Points: 
  • We know that bystander CPR saves lives, and we hope these videos will connect with people and help them overcome any fears or hesitations."
  • Teams participating in the three-minute videos include the Washington Wizards, Washington Capitals, Washington Mystics, and Georgetown Women's Soccer.
  • Recent changes to the way CPR can be administered should also make the public feel more comfortable performing CPR, according to MedStar Health physicians.
  • MedStar Health social media channels are running the videos that will also be shared by the teams.

Propanc Biopharma’s Intellectual Property Portfolio Makes Important Advancements in Europe

Retrieved on: 
Thursday, May 25, 2023

Propanc Biopharma, Inc. (OTC Pink: PPCBD) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s intellectual property (IP) portfolio made important advancements in Europe.

Key Points: 
  • Propanc Biopharma, Inc. (OTC Pink: PPCBD) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s intellectual property (IP) portfolio made important advancements in Europe.
  • The dosing patent, describing claims for the dosing regimen of the Company’s lead product candidate, PRP, has now been validated in 12 countries across Europe.
  • This is the third patent allowed, or granted to the Company in Europe, with further applications under examination by the EPO.
  • As a result of validating the dosing patent across Europe, the Company’s IP portfolio has grown to 76 patents either allowed, or granted in major jurisdictions around the world.

Propanc Biopharma’s Intellectual Property Portfolio Achieves Significant Milestones in North America

Retrieved on: 
Tuesday, May 23, 2023

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s intellectual property (IP) portfolio achieved significant milestones in North America.

Key Points: 
  • Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s intellectual property (IP) portfolio achieved significant milestones in North America.
  • The foundation patent, covering composition claims for the Company’s lead product candidate, PRP, received a notice of allowance from the Canadian Intellectual Property Office (CIPO).
  • Propanc has an accepted application or achieved grant status for the foundation patent in over 30 different countries across North America, Europe, Asia, the Middle East and Japan.
  • “The milestones achieved for our intellectual property portfolio in North America are highly significant, as we now have patents in force in every jurisdiction selected by the Company for future commercialization of PRP,” said James Nathanielsz, BAS, MEI, Propanc’s Chief Executive Officer.